Aleksandra Shcherbak
Nurse Practitioner · Pittsburgh, PANPI 1629774351
Payments from drug & device makers
Across 145 payments — averaging $29.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$1K
- Sanofi$325
- Regeneron Healthcare Solutions, Inc.$313
- Edwards Lifesciences$149
- Amgen$147
- plus $920 from 17 others
What the payments were for
- Food & beverage$4,14095%
- Education$2035%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 47 | $1,276 |
| AstraZeneca(2 entities) | 38 | $1,213 |
| Sanofi | 15 | $325 |
| Regeneron Healthcare Solutions, Inc. | 8 | $313 |
| Edwards Lifesciences | 1 | $149 |
| Amgen | 3 | $147 |
| Actelion Pharmaceuticals US, Inc. | 3 | $135 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Verona Pharma, Inc. | 3 | $83 |
| Electromed, Inc. | 3 | $71 |
| Boehringer Ingelheim | 3 | $67 |
| Vifor Pharma, Inc. | 3 | $63 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $51 |
| Pulmonx Corporation | 2 | $50 |
| Pfizer | 2 | $45 |
| Lilly USA, LLC | 2 | $39 |
| Insmed, Inc. | 2 | $38 |
| Harmony Biosciences LLC | 1 | $35 |
| Baxter Healthcare | 1 | $33 |
| Novartis | 1 | $33 |
| Merck | 1 | $32 |
| Mylan Specialty L.p. | 2 | $29 |
| ZOLL Respicardia, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,343 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $13,354 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,197 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $589 |
| Prednisone | 229 | $418 |
| Doxycycline Hyclate | 83 | $353 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 49 | $336 |
| CefuroximeCefuroxime Axetil | 38 | $331 |
| Azithromycin | 54 | $182 |
| Ciprofloxacin Hcl | 17 | $74 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $1,276 | $17,55133 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Pittsburgh
- Suzanne KlutchPittsburgh$35K
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.